KANSAS CITY, Mo. — Less than one week into the state allowing the medical marijuana sales, the Missouri Department of Health and Senior Services is investigating a complaint that a product “contained mold growth.”
All patients, facilities and caregivers “associated with this product batch have been notified,” according to a news release, and have been instructed to halt use of it until after the investigation.
“The track and trace system is greatly aiding our team in this investigation and allowing us to quickly identify and notify all who may be impacted by this particular batch,” Lyndall Fraker, director of the DHSS Section for Medical Marijuana Regulation, said in a news release. “A well-regulated program allows for this type of quick action so that we can protect patients.”
Sales from the batch in question have been suspended. Though it passed required testing ahead of sale, more testing is taking place to “determine the source of the mold,” the release stated.
Missouri began on Saturday allowing dispensaries to sell medical marijuana.
